Omaxe Ltd closes trading window from July 1 till 48 hours after Q1FY27 results
Omaxe Ltd has closed its trading window for designated persons effective July 1, 2026, in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015. The window will remain shut until 48 hours after the declaration of unaudited financial results for the quarter ending June 30, 2026. The board meeting date for results consideration will be intimated later.

*this image is generated using AI for illustrative purposes only.
Omaxe Ltd has closed its trading window for designated persons and their immediate relatives effective from July 1, 2026. This closure is in compliance with the SEBI (Prohibition of Insider Trading) Regulations, 2015, and the company's internal code of conduct for the prevention of insider trading. The restriction ensures that no insider trading occurs while the company is in the process of finalizing its financial results for the quarter ending June 30, 2026.
The trading window will remain closed until 48 hours after the declaration of the unaudited financial results, both standalone and consolidated, for the quarter ending June 30, 2026. During this period, designated persons and their immediate relatives are strictly advised not to trade or deal in the securities of the company. The specific date for the board meeting, where these results will be considered and declared, will be communicated in due course.
Compliance and Regulatory Framework
The closure of the trading window is a standard regulatory measure to prevent the misuse of unpublished price-sensitive information (UPSI). By restricting trading activities around the announcement of financial results, Omaxe Ltd aims to maintain transparency and protect the interests of its shareholders. The company has made this intimation available on its official website and the websites of the BSE and NSE.
Key Dates and Restrictions
| Event | Date/Time |
|---|---|
| Trading Window Closure | July 1, 2026 |
| Quarter Ending | June 30, 2026 |
| Trading Window Reopens | 48 hours after Q1FY27 results declaration |
| Board Meeting Date | To be intimated later |
The intimation was signed by D B R Srikanta, Company Secretary & Compliance Officer of Omaxe Ltd, on June 22, 2026. Shareholders and investors are advised to take note of the trading restrictions to avoid any inadvertent violations.
Historical Stock Returns for Omaxe
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +0.09% | -1.71% | +4.59% | -3.56% | -24.99% | -4.79% |
How might the closure of the trading window influence investor sentiment ahead of the Q1FY27 financial results?
What are the expected key performance indicators in the upcoming unaudited results that could impact Omaxe Ltd's stock price?
Could the extended trading restriction signal any significant strategic announcements or changes in the company's financial outlook?

































